BTC Health Ltd (ASX: BTC) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
BTC Health Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$16.92 million
P/E Ratio
4.13
Dividend Yield
0.00%
Shares Outstanding
325.32 million
Earnings per share
0.013
Dividend per share
N/A
Year To Date Return
-28.77%
Earnings Yield
24.23%
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
BTC Health Ltd (ASX: BTC)
Latest News
⏸️ Investing
6 listed funds with tax free capital gains and dividends
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 05 Jul 2011 | $0.0280 | 0.00% | Special Cash | 15 Jul 2011 |
| 03 Sep 2010 | $0.0140 | 0.00% | Final | 13 Sep 2010 |
BTC ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About BTC Health Ltd
BTC Health Ltd is a pooled development fund. The company is seeking new investment opportunities in entities operating in the biotechnology/life-science sectors. Its only operating segment is the making and managing of healthcare ventures.The company's products include Rythmic Infusion Pumps, Elasto-Q, ambIT, Infusion and Nerve Catheter Kits, Tiva, Rebellion - Bone Removal System, Ilumark, COLIBRI, ECMOLIFE, ECLS Heaters Coolers.
BTC Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 19 Jun 2025 | $0.05 | $0.00 | 0.00% | 46,582 | $0.05 | $0.05 | $0.05 |
| 16 Jun 2025 | $0.05 | $0.00 | 0.00% | 118,800 | $0.05 | $0.05 | $0.05 |
| 13 Jun 2025 | $0.05 | $0.00 | 0.00% | 10,000 | $0.05 | $0.05 | $0.05 |
| 12 Jun 2025 | $0.05 | $0.00 | 0.00% | 2,500 | $0.05 | $0.05 | $0.05 |
| 11 Jun 2025 | $0.05 | $0.00 | 0.00% | 35,227 | $0.05 | $0.05 | $0.05 |
| 05 Jun 2025 | $0.05 | $0.00 | 0.00% | 4,000 | $0.05 | $0.05 | $0.05 |
| 04 Jun 2025 | $0.05 | $0.00 | 0.00% | 50,322 | $0.05 | $0.05 | $0.05 |
| 03 Jun 2025 | $0.05 | $0.00 | 0.00% | 10,003 | $0.05 | $0.05 | $0.05 |
| 29 May 2025 | $0.05 | $0.00 | 0.00% | 99,321 | $0.05 | $0.05 | $0.05 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 19 Mar 2025 | Richard Treagus | Buy | 118,546 | $6,285 |
On-market trade.
|
| 27 Jun 2024 | Richard Treagus | Buy | 185,515 | $7,094 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Dr Richard Spencer Treagus | Executive ChairmanExecutive Director | Aug 2014 |
Dr Treagus has over 25 years of experience in all aspects of the international pharmaceutical and biotechnology industry.
|
| Ms Felicity McNeill | Non-Executive Director | Oct 2022 |
Ms McNeill has over 25 years of experience across the public and private sector including almost 15 years in the regulatory and subsidy systems for medicines, vaccines, devices and diagnostics in Australia.
|
| Mr Martin Kahanovitz | Non-Executive Director | Jun 2025 |
Mr. Kahanovitz is the Chief Financial Officer of the Kahma Healthcare Group. He also serves as Director forThe Biologicals and Vaccine Institute of Southern Africa (Pty) Ltd t/a Biovac and as Chairperson for the Finance and Risk Board Committee. Mr. Kahanovitz is a registered Director with nearly 30 years of professional experience in the biotechnology, pharmaceutical, and medical industries. He is a successful entrepreneur, demonstrated by his role as a key architect in establishing a major bio-pharmaceutical company connected to global vaccine players, creating a leading JSE-listed integrated healthcare company that was acquired by an international pharmaceutical firm, and forming a unique group of synergistic healthcare companies with a diverse range of interests.
|
| Mr Salesh Balak | Chief Financial OfficerCompany Secretary | Mar 2025 |
-
|
| Salesh Balak | Chief Financial OfficerCompany Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| J P Morgan Nominees Australia Pty Limited | 94,738,597 | 29.23% |
| Mrs Karen Elizabeth Treagus | 29,561,515 | 9.12% |
| Sigma Company Limited | 16,856,467 | 5.20% |
| Namarong Investments Pty Ltd | 15,000,000 | 4.63% |
| Glk Medical Pty Ltd | 14,092,318 | 4.35% |
| Kingfisher Medical Pty Ltd | 14,092,318 | 4.35% |
| Tau Investments Australia Pty Ltd | 14,092,318 | 4.35% |
| Mr Thomas Christopher Fennell | 8,682,787 | 2.68% |
| Mr Campbell Dinwoodie Taylor | 8,393,127 | 2.59% |
| Sigma Company Limited i | 8,143,533 | 2.51% |
| Argus Nominees Pty Ltd | 5,500,000 | 1.70% |
| Mrs Susan Maree Whiting | 5,300,000 | 1.64% |
| Citicorp Nominees Pty Limited | 4,543,617 | 1.40% |
| Windarri Investments Pty Ltd | 4,213,727 | 1.30% |
| Abeille Investments Pty Limited | 3,800,000 | 1.17% |
| Mr Nicholas Dermott Mcdonald | 3,644,239 | 1.12% |
| Sigma Company Limited ii | 3,627,553 | 1.12% |
| Namarong Investments Pty Ltd i | 3,125,000 | 0.96% |
| Linwierik Investments Pty Ltd | 2,600,000 | 0.80% |
| Chanuk Nominees Pty Ltd | 2,000,000 | 0.62% |
| Pritdown Pty Ltd | 2,000,000 | 0.62% |
